Cystic Fibrosis

December 17, 2015December 17, 2015

Quick ‘Breath Test’ Detects Tularemia, and Possibly CF, COPD and Tuberculosis

Cystic Fibrosis, News

Researchers at the University of New Mexico have developed an innovative technology for quickly and easily detecting pneumonic tularemia infection, a severe form of the disease, and recently were issued a patent for ... Read more

December 15, 2015December 15, 2015

Cystic Fibrosis Study Planned for Adults with Diabetes and Liver Disease

Cystic Fibrosis, News

ProMetic Life Sciences Inc., a biopharmaceutical company developing bioseparations, plasma-derived therapeutics and small-molecule therapies, announced this week that it is planning to commence a Phase 2 double-blind, placebo-controlled clinical trial of its ... Read more

December 11, 2015December 11, 2015

PEPs Found Effective in Reducing Flare-ups in Cystic Fibrosis Patients

Cystic Fibrosis, News

A recent study reviewed the effectiveness of positive expiratory pressure (PEP) physiotherapy devices in clearing airways of cystic fibrosis (CF) patients and found that PEP vests do reduce pulmonary exacerbations. ... Read more

December 3, 2015December 3, 2015

Cystic Fibrosis Phase 2 Study of CFTR Stabilizer Begins Treatments

Cystic Fibrosis, News

Nivalis Therapeutics, Inc., announced that a Phase 2 clinical study of its lead investigational drug N91115 has begun treating its first patient. Nivalis, a pharmaceutical company focused on cystic fibrosis (CF) treatments, developed N91115 ... Read more

November 23, 2015November 23, 2015

CF Fungus Found to Adapt to and Resist Rival Bacteria

Cystic Fibrosis, News

A newly published study suggests that a fungal species found in the lungs of patients with cystic fibrosis (CF) develops a genetic mutation that allows it to adapt to and ... Read more

November 23, 2015November 23, 2015

PTC Therapeutics’ CF Therapy in 2nd Fully Enrolled Phase 3 Trial

Cystic Fibrosis, News

PTC Therapeutics announced that it has completed patient enrollment in its second Phase 3 clinical trial, known as ACT CF, to evaluate Translarna™ (ataluren) as treatment for patients with nonsense mutation cystic fibrosis ... Read more

November 19, 2015

Vertex’s Cystic Fibrosis Therapy Expands to Younger Children, More Adults

Cystic Fibrosis, News

Vertex Pharmaceuticals Inc. recently confirmed that the European Commission has expanded the indication of Kalydeco® (ivacaftor) to two more groups of patients: children ages 2 to 5 with cystic fibrosis (CF) who have at least ... Read more

November 19, 2015

Cystic Fibrosis Study Explores Steps in Intestinal Inflammation

Cystic Fibrosis

A new study revealed that the cystic fibrosis transmembrane conductance regulator (CFTR) plays an important role in regulating intestinal inflammatory responses. The study, entitled “CFTR Knockdown induces pro inflammatory changes ... Read more

November 17, 2015November 17, 2015

Gene Therapy for Cystic Fibrosis Shows Early Potential as Therapy

Cystic Fibrosis, News

Recent research suggests that treatment of cystic fibrosis (CF) by means of improved gene therapy might one day be possible, having shown promising results in a mouse model and cultured cells ... Read more

November 17, 2015November 17, 2015

Arch Biopartners’ Cystic Fibrosis Therapy Given Orphan Drug Designation

Cystic Fibrosis, News

Arch Biopartners Inc., a biotechnology company focused on the development of new technologies with clinical relevance, has announced that its investigational drug AB569 has been granted Orphan Drug Designation by the U.S. Food ... Read more